ANN ARBOR – Blaze Medical Devices has added two new members to its advisory board, CPA Paul Glantz and finance professional Terry Cross.

Blaze is a medical device company focusing on increasing the efficacy and safety of transfusions while reducing transfusion-related costs and reducing the use of blood. Blood units differ in properties based on donor-to-donor differences and processing differences, resulting in significant and unpredictable variability in transfusion outcomes. Blaze is working with hospital blood bankers and transfusion physicians to provide tests which can meet their growing desire to access more knowledge about individual units of blood product for better patient outcome. Blaze also researches potential correlations between in vitro Red Blood Cell properties and their in vivo behavior or performance.

Glantz holds a Bachelor of Science Degree in Business Administration with High Distinction from Wayne State University and a Master?s Degree in Taxation from Walsh College. Glantz also possesses an in-depth understanding of business, having acquired substantial experience through progressively more responsible positions in finance, insurance, real estate and cinematic exhibition. Since 1989 Glantz has focused his efforts on building entrepreneurial businesses. Particularly noteworthy was his decision, in October 1990, to assume the position of Vice President of Finance & Administration with Proctor Financial, a leading provider of specialized insurance services to mortgage servicers nationwide.

Cross, after graduating from Wayne State University with an MBA in Finance, entered the machine tool business in Detroit with The Cross Company, (publicly traded) the world?s leader in Automated Machine Tools. Cross entered the securities business through a training program with Eastman Dillon Union Securities in 1972. Cross founded Windward Associates, a private investment partnership, where he focuses on capital formation advisory.

Current Advisory Board:

Timothy Faley, PhD, MBA: Tim is assuming the role of ?Advisor Emeritus?. While we appreciate Tim?s excellent counsel, unfortunately his increasingly hectic schedule no longer allows for regular guidance. He will continue to be available to us for special consultations. He currently serves as a Managing Director of UM?s Zell-Lurie Institute for Entrepreneurial Studies, and was founding Director of the UM College of Engineering?s Technology Transfer Office. He came to the University from the Dow Chemical Company, where he worked in research, new business development, and corporate venturing. He has been associated with seventeen new ventures throughout his career.

James E. Nicholson: Jim has an impressive track record in the medical device industry as the founder of several medical device start-up companies including Mitek Surgical Products, Innovasive Devices, and Cortek, Inc. Eyetect is Jim’s seventh venture. He led both Mitek and Innovasive through successful IPOs and both companies were subsequently acquired by Johnson & Johnson. He serves as an advisor or Director on several companies. Jim holds BS/MS degrees from MIT in Aeronautical Engineering and has been awarded 40 patents.